Capricorn Fund Managers Ltd
•CIK: 1901361•Filing: Q4 2025
**Capricorn Fund Managers Ltd** Manages $415M across a diversified portfolio of 82 positions. The fund exhibits notable concentration in the biotech and technology sectors, highlighted by significant allocations to ZYME ($26.9M) and WAY ($24.2M). Further top holdings include GPCR ($17.6M), NUVB ($14.2M), and MSFT ($13.9M), suggesting a focused, high-conviction approach to growth and innovation.
Total AUM
$414.9M
QoQ Performance
+39.3%
Positions
82
Top 10 Concentration
36.0%
Latest Filing
Q4 2025
Top Holdings Allocation
ZYME
WAY
ZYME6.5%
WAY5.8%
GPCR4.2%
NUVB3.4%
MSFT3.3%
GH2.7%
AMZN2.7%
Karooooo2.6%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other79.7%
Technology7.1%
Financial4.4%
Consumer4.1%
Healthcare1.0%
Industrial0.9%
Consumer Staples0.9%
Materials0.8%
🚪 Exited Positionssold since Q3 2025
+19 more exited positions
Changes from Q3 2025
NEW47 new positions
↑17 increased
↓15 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023